| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Caragol William J | Chief Financial Officer | MAINZ BIOMED N.V., ROBERT KOCH STRASSE 50, MAINZ | /s/ William Caragol | 19 Feb 2026 | 0001380465 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MYNZ | Ordinary Shares | Award | $0 | +290,000 | +372% | $0.000000 | 367,899 | 13 Feb 2026 | Direct | F1, F2 |
| Id | Content |
|---|---|
| F1 | Grant of restricted shares under Mainz Biomed N.V. 2025 Omnibus Incentive Plan; no cash consideration paid. |
| F2 | 77,899 employee stock options were granted and previously reported on a Form 3 filed January 26, 2026. |